Robert K Brooner Selected Research

Opioid Analgesics (Opioids)

6/2022	Opioid treatment program prescribing of methadone with community pharmacy dispensing: Pilot study of feasibility and acceptability.
1/2021	Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report.
10/2018	Psychiatric and Substance Use Comorbidity in Treatment-Seeking Injection Opioid Users Referred From Syringe Exchange.
1/2014	Challenges and outcomes of parallel care for patients with co-occurring psychiatric disorder in methadone maintenance treatment.
11/2013	Reinforcing integrated psychiatric service attendance in an opioid-agonist program: a randomized and controlled trial.
11/2013	Managing psychiatric comorbidity within versus outside of methadone treatment settings: a randomized and controlled evaluation.
5/2013	An observation of lower rates of drug use over time in community syringe exchangers.
3/2010	Using enhanced and integrated services to improve response to standard methadone treatment: changing the clinical infrastructure of treatment networks.
5/2009	Improving substance abuse treatment enrollment in community syringe exchangers.
1/2008	A behavioral treatment for opioid-dependent patients with antisocial personality.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert K Brooner Research Topics

Disease

22	Substance-Related Disorders (Drug Abuse) 01/2022 - 05/2004
12	Opioid-Related Disorders (Opiate Addiction) 06/2022 - 09/2006
9	Mental Disorders (Mental Disorder) 02/2021 - 01/2008
5	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020 - 01/2013
2	Personality Disorders (Personality Disorder) 02/2021 - 10/2018
2	COVID-19 01/2021 - 01/2021
2	Antisocial Personality Disorder (Antisocial Personality) 03/2016 - 01/2008
2	Chronic Pain 09/2014 - 08/2008
1	Coinfection 01/2022
1	Anhedonia 01/2021
1	Pain (Aches) 09/2014
1	Alcoholism (Alcohol Abuse) 01/2014

Drug/Important Bio-Agent (IBA)

19	Methadone (Dolophine)FDA LinkGeneric 06/2022 - 09/2006
14	Opioid Analgesics (Opioids)IBA 06/2022 - 05/2004
8	Cocaine (Cocaine HCl)IBA 12/2019 - 07/2005
3	Heroin (Diamorphine)IBA 05/2014 - 01/2013
2	Matrix Metalloproteinases (MMPs)IBA 12/2019 - 01/2019
2	Illicit Drugs (Recreational Drugs)IBA 11/2013 - 04/2005
1	sofosbuvir drug combination ledipasvirIBA 01/2022
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2022
1	RV 538 (PDMP)IBA 01/2022
1	TabletsIBA 01/2022
1	Hypnotics and Sedatives (Sedatives)IBA 10/2018
1	BenzodiazepinesIBA 09/2014
1	Analgesics (Analgesic Drugs)IBA 09/2014
1	trans-crotonin (CTN)IBA 08/2009
1	Buprenorphine (Subutex)FDA LinkGeneric 09/2006
1	Methadyl Acetate (LAAM)FDA Link 09/2006

Therapy/Procedure

3	Therapeutics 01/2020 - 10/2004
2	Pain Management 09/2014 - 08/2008
1	Micro-Electrical-Mechanical Systems 03/2016
1	Drug Therapy (Chemotherapy) 04/2015
1	Injections 05/2009
1	Long-Term Care 04/2008
1	Opiate Substitution Treatment 01/2008